Skip to main content
. 2019 Sep 18;15(3):328–337. doi: 10.5114/aic.2019.87887

Table IV.

Factors associated with in-stent restenosis identified by univariate and multivariate Cox proportional hazard analysis

Parameter Univariate Cox proportional hazard analysis HR (95% CI); p-level Multivariate Cox proportional hazard analysis HR (95% CI); p-level
Age 0.96 (0.94–0.99); 0.002 0.96 (0.92–0.99); 0.05
Hyperlipidemia 0.85 (0.27–2.69); 0.78
Hypertension 0.58 (0.08–4.15); 0.58
Intervention on RVA vs. LVA 0.92 (0.59–1.42); 0.69
Stent diameter 5.58 (0.01–17.2); 0.912
Stent length 1.43 (0.01–8.28); 0.988
CRP 1.01 (0.98–1.04); 0.36
Stent type:
 Stainless steel/cobalt chromium vs. platinum-chromium BMS 0.22 (0.10–0.78); 0.001 0.28 (0.13–0.64); 0.002
 Paclitaxel/zotarolimus vs. biolimus/everolimus DES 0.55 (0.27–1.15); 0.114